$100.20-1.03 (-1.02%)
News5/Ratings0
Price$100.20-5.51 (-5.21%)
2026-01-212026-04-24
Latest news
5 items- PRVanEck Announces Year-End Distributions for VanEck Equity ETFsVanEck announced today the following 2024 annual distributions per share for its VanEck® equity exchange-traded funds. Distributions Per Share for the VanEck ETFs Listed Below Ex-Date: December 23, 2024 | Record Date: December 23, 2024 | Payable Date: December 24, 2024 Fund Ticker Income Approximate % of Income from PFICs Short-Term Capital Gain Long-Term Capital Gain VanEck Africa Index ETF AFK None None None None VanEck Biotech ETF BBH $ 1.2517 22% None None VanEck Gaming ETF BJK $ 1.1667 34% None None VanEck Brazil Small-Cap
- NEWSOzempic Maker Novo Nordisk Closes In On Lego As Denmark's Most Valuable Brand: ReportPharmaceutical giant Novo Nordisk A/S (NYSE:NVO) is reportedly set to overtake Denmark’s iconic toymaker, Lego A/S, as the nation’s most valuable brand. For now, Lego continues to hold the title of the nation’s most valuable brand, a position it has maintained for nine consecutive years. However, the pharmaceutical giant is rapidly gaining ground, thanks to the surging popularity of its weight-loss drugs on a global scale. Lego’s brand value has modestly increased by 3% in the past year, reaching approximately $8 billion. In contrast, Novo Nordisk’s brand value soared by 59% to $5.1 billion, reported Bloomberg, citing the latest 2024 country rankings by Brand Finance, released on We
- NEWSNovo Nordisk's Game-Changer: FDA Approves Weight Loss Sensation Wegovy For Heart Health, Potential Insurance CoverageNovo Nordisk A/S (NYSE:NVO)’s Wegovy garnered the Food and Drug Administration’s approval for expanded use Friday, marking what the drugmaker said is a pivotal turn in the treatment landscape for individuals grappling with the dual challenges of obesity and established cardiovascular disease. This approval underscores a new era in preventive health strategies, targeting a significant reduction in major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal heart attacks (myocardial infarction) and nonfatal strokes. Leap Forward In Cardiovascular, Weight Management Therapy The FDA’s green light is anchored in the evidence from the SELECT cardiovascular outcom
- NEWS11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher YieldsWhile many of the world’s investors remain focused on "The Magnificent Seven" — a group of tech stocks that significantly outperformed in 2023 — a small group of European stocks has quietly outperformed most of the world. Based on the first letters of their names, Goldman Sachs dubbed this group “Granolas,” and it accounted for 50% of gains of the Stoxx Europe 600 Index for the past year. Who are the Granolas? Granolas refers to a group of 11 European stocks operating in the healthcare and pharmaceutical sector, with an addition of luxury, consumer staples, industrial manufacturing and software technology. They include: GSK plc (NYSE:GSK): The pharmaceutical company, founded in
- NEWSBiden-Harris Administration Moves Forward with Medicare Drug Price Negotiations to Lower Prescription Drug Costs for People with Medicare
PPH FAQ
7 questionsWhat does VanEck Vectors Pharmaceutical ETF do?
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.Where does PPH stock trade?
VanEck Vectors Pharmaceutical ETF (PPH) is listed on NASDAQ.What sector and industry is PPH in?
VanEck Vectors Pharmaceutical ETF operates in the n/a sector.When did VanEck Vectors Pharmaceutical ETF go public?
VanEck Vectors Pharmaceutical ETF (PPH) completed its IPO in n/a.Does PPH pay a dividend?
PPH's most recent ex-dividend date was 2026-04-01 with a cash dividend of $0.84 per share. No future ex-date is on file yet.What companies are similar to PPH?
Notable peers in the same industry include CBOE (Cboe Global Markets, Inc.), HCXY (Hercules Capital, Inc.), PCI (PIMCO Dynamic Credit and Mortgage Income Fund), BXS (BancorpSouth Bank), AJAX (Ajax I). Compare PPH side-by-side with any of them on Quantisnow.How can I track PPH on Quantisnow?
Quantisnow aggregates VanEck Vectors Pharmaceutical ETF's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PPH to receive live email and push alerts on every new disclosure.